3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter / financial year ended 31st March 2026 and to discuss the matter of recommendation of dividend if any for the financial year ended 31st March 2026.